Study to Evaluate the Safety and Efficacy of CAT-354
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
This is a Phase 2a, randomized, double-blind, placebo-controlled, parallel-arm study to
evaluate the efficacy and safety of three subcutaneous (SC) treatment regimens of CAT-354 in
adult subjects with uncontrolled, moderate-to-severe, persistent asthma.